ArticleThe Journal of biological chemistry2026

Ganaxolone, an approved therapy for CDKL5-deficiency disorder, is an inhibitor of PTP1B.

Imanol Zubiete-Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.